Iovance Biotherapeutics, Inc. (IOVA)

2.235 +0.08 (+3.47%) USD  |  NASDAQ  |  Dec 16, 16:00
2.24 0.00 (0.00%) After-Hours: 20:00
More

Iovance Biotherapeutics Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for IOVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Lantheus Holdings, Inc. Upgrade
Day One Biopharmaceuticals, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
Xenetic Biosciences, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade